18264316. COMBINED NEUROMODULATION TECHNIQUES simplified abstract (GE Precision Healthcare LLC)

From WikiPatents
Revision as of 06:34, 1 October 2024 by Wikipatents (talk | contribs) (Creating a new page)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

COMBINED NEUROMODULATION TECHNIQUES

Organization Name

GE Precision Healthcare LLC

Inventor(s)

Christopher Michael Puleo of Niskayuna NY (US)

Victoria Eugenia Cotero of Troy NY (US)

Jeffrey Michael Ashe of Gloversville NY (US)

COMBINED NEUROMODULATION TECHNIQUES - A simplified explanation of the abstract

This abstract first appeared for US patent application 18264316 titled 'COMBINED NEUROMODULATION TECHNIQUES

    • Simplified Explanation:**

The patent application discusses the use of combined neuromodulation techniques to treat metabolic disorders, which may involve dual-site or single-site neuromodulation in combination with pharmaceutical treatment.

    • Key Features and Innovation:**

- Combined neuromodulation techniques for treating metabolic disorders - Dual-site or single-site neuromodulation options - Administration of neuromodulation in combination with pharmaceutical treatment

    • Potential Applications:**

- Treatment of metabolic disorders such as diabetes or obesity - Management of symptoms related to metabolic conditions - Potential use in research studies on neuromodulation and metabolic disorders

    • Problems Solved:**

- Addressing the need for effective treatment options for metabolic disorders - Providing a potential alternative or complementary therapy to pharmaceutical treatments alone

    • Benefits:**

- Improved management of metabolic disorders - Potential for personalized treatment plans combining neuromodulation and pharmaceuticals - Enhanced understanding of the role of neuromodulation in metabolic conditions

    • Commercial Applications:**

Title: Neuromodulation Techniques for Metabolic Disorder Treatment Potential commercial uses include medical devices for neuromodulation therapy, pharmaceutical companies developing combination treatments, and research institutions studying metabolic disorders.

    • Questions about Combined Neuromodulation Techniques for Metabolic Disorders:**

1. How do combined neuromodulation techniques compare to traditional pharmaceutical treatments for metabolic disorders? 2. What are the potential long-term effects of using neuromodulation in combination with pharmaceutical treatment for metabolic disorders?


Original Abstract Submitted

Combined neuromodulation techniques are disclosed to treat metabolic disorders. The combined neuromodulation techniques may include dual-site neuromodulation or single-site neuromodulation. In embodiments, the neuromodulation may be administered as a combined therapy with a pharmaceutical treatment.